Biomarkers in acute kidney injury – pathophysiological basis and clinical performance

Acta Physiologica

Volumn 219, Issue 3, 2017, Pages 554-572

  Schrezenmeier, E V ^a,b   Barasch, J ^c   Budde, K ^a   Westhoff, T ^d   Schmidt Ott, K M ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

acute kidney injury; biomarkers; calprotectin; kidney injury molecule 1 (KIM 1); neutrophil gelatinase associated lipocalin (NGAL); tissue inhibitor of metalloproteinase 2 (TIMP 2) and IGF binding protein 7 (IGFBP7)

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; CREATININE; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; URINE VOLUME; ACUTE KIDNEY INJURY; METABOLISM;

ACUTE KIDNEY INJURY; BIOMARKERS; HUMANS;

EID: 84983450413     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12764     Document Type: Review

References (155)

1. Altwegg, L.A., Neidhart, M., Hersberger, M., Müller, S., Eberli, F.R., Corti, R., Roffi, M., Sütsch, G., Gay, S., von Eckardstein, A., Wischnewsky, M.B., Lüscher, T.F. & Maier, W. 2007. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 28, 941–948.
2. Amin, R.P., Vickers, A.E., Sistare, F., Thompson, K.L., Roman, R.J., Lawton, M., Kramer, J., Hamadeh, H.K., Collins, J., Grissom, S. et al. 2004. Identification of putative gene based markers of renal toxicity. Environ Health Perspect 112, 465–479.
3. Arthur, J.M., Hill, E.G., Alge, J.L., Lewis, E.C., Neely, B.A., Janech, M.G., Tumlin, J.A., Chawla, L.S., Shaw, A.D. & SAKInet Investigators. 2014. Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. Kidney Int 85, 431–438.
4. Attridge, R.L., Linn, W.D., Ryan, L., Koeller, J. & Frei, C.R. 2012. Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity. J Clin Lipidol 6, 19–26.
5. Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M. & Bonventre, J.V. 2002. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J Biol Chem 277, 39739–39748.
6. Bao, G., Clifton, M., Hoette, T.M., Mori, K., Deng, S.-X., Qiu, A., Viltard, M., Williams, D., Paragas, N., Leete, T. et al. 2010. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 6, 602–609.
7. Bell, M., Granath, F., Mårtensson, J., Löfberg, E., Ekbom, A. & Martling, C.-R. & KING (Karolinska Intensive care Nephrology Group). 2009. Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant 24, 3096–3102.
8. Bell, M., Larsson, A., Venge, P., Bellomo, R. & Mårtensson, J. 2015. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury. Dis Markers 2015, 158658.
9. Bellomo, R., Kellum, J.A. & Ronco, C. 2012. Acute kidney injury. Lancet 380, 756–766.
10. Bennett, M., Dent, C.L., Ma, Q., Dastrala, S., Grenier, F., Workman, R., Syed, H., Ali, S., Barasch, J. & Devarajan, P. 2008. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3, 665–673.
11. Bihorac, A., Yavas, S., Subbiah, S., Hobson, C.E., Schold, J.D., Gabrielli, A., Layon, A.J. & Segal, M.S. 2009. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 249, 851–858.
12. Bihorac, A., Chawla, L.S., Shaw, A.D., Al-Khafaji, A., Davison, D.L., Demuth, G.E., Fitzgerald, R., Gong, M.N., Graham, D.D., Gunnerson, K. et al. 2014. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189, 932–939.
13. Bolignano, D., Basile, G., Parisi, P., Coppolino, G., Nicocia, G. & Buemi, M. 2009. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res 12, 7–14.
14. Brun, J.G., Madland, T.M., Gran, J.T. & Myklebust, G. 2005. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity. Scand J Rheumatol 34, 125–128.
15. Cai, L., Rubin, J., Han, W., Venge, P. & Xu, S. 2010. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 5, 2229–2235.
16. Chang, A., Ko, K. & Clark, M.R. 2014. The emerging role of the inflammasome in kidney diseases. Curr Opin Nephrol Hypertens 23, 204–210.
17. Chang, C.-H., Yang, C.-H., Yang, H.-Y., Chen, T.-H., Lin, C.-Y., Chang, S.-W., Chen, Y.-T., Hung, C.-C., Fang, J.-T., Yang, C.-W. & Chen, Y.-C. 2015. Urinary biomarkers improve the diagnosis of intrinsic acute kidney injury in coronary care units. Medicine (Baltimore) 94, e1703.
18. Chawla, L.S., Amdur, R.L., Shaw, A.D., Faselis, C., Palant, C.E. & Kimmel, P.L. 2014a. Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol 9, 448–456.
19. Chawla, L.S., Eggers, P.W., Star, R.A. & Kimmel, P.L. 2014b. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371, 58–66.
20. Chawla, L.S., Goldstein, S.L., Kellum, J.A. & Ronco, C. 2015. Renal angina: concept and development of pretest probability assessment in acute kidney injury. Crit Care 19, 93.
21. Cheung, H., Chen, N.-J., Cao, Z., Ono, N., Ohashi, P.S. & Yeh, W.-C. 2005. Accessory protein-like is essential for IL-18-mediated signaling. J Immunol 174, 5351–5357.
22. Chindarkar, N.S., Chawla, L.S., Straseski, J.A., Jortani, S.A., Uettwiller-Geiger, D., Orr, R.R., Kellum, J.A. & Fitzgerald, R.L. 2016. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI. Clin Chim Acta 452, 32–37.
23. Chmurzyńska, A. 2006. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 47, 39–48.
24. Coca, S.G., King, J.T., Rosenthal, R.A., Perkal, M.F. & Parikh, C.R. 2010. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 78, 926–933.
25. Coca, S.G., Garg, A.X., Thiessen-Philbrook, H., Koyner, J.L., Patel, U.D., Krumholz, H.M., Shlipak, M.G., Parikh, C.R. & Parikh, C.R. 2014. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 25, 1063–1071.
26. Cruz, D.N., Bagshaw, S.M., Maisel, A., Lewington, A., Thadhani, R., Chakravarthi, R., Murray, P.T., Mehta, R.L. & Chawla, L.S. 2013. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. Contrib Nephrol 182, 45–64.
27. Cullen, M.R., Murray, P.T. & Fitzgibbon, M.C. 2012. Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin. Ann Clin Biochem 49, 190–193.
28. Dale, I., Fagerhol, M.K. & Naesgaard, I. 1983. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 134, 1–6.
29. Dent, C.L., Ma, Q., Dastrala, S., Bennett, M., Mitsnefes, M.M., Barasch, J. & Devarajan, P. 2007. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 11, R127.
30. Dessing, M.C., Tammaro, A., Pulskens, W.P., Teske, G.J., Butter, L.M., Claessen, N., van Eijk, M., van der Poll, T., Vogl, T., Roth, J., Florquin, S. & Leemans, J.C. 2015. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int 87, 85–94.
31. Devarajan, P. 2007. Emerging biomarkers of acute kidney injury. Contrib Nephrol 156, 203–212.
32. Dieterle, F., Sistare, F., Goodsaid, F., Papaluca, M., Ozer, J.S., Webb, C.P., Baer, W., Senagore, A., Schipper, M.J., Vonderscher, J. et al. 2010. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 28, 455–462.
33. Doi, K., Negishi, K., Ishizu, T., Katagiri, D., Fujita, T., Matsubara, T., Yahagi, N., Sugaya, T. & Noiri, E. 2011. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med 39, 2464–2469.
34. Ebbing, J., Mathia, S., Seibert, F.S., Pagonas, N., Bauer, F., Erber, B., Günzel, K., Kilic, E., Kempkensteffen, C., Miller, K., Bachmann, A., Rosenberger, C., Zidek, W. & Westhoff, T.H. 2014. Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder. World J Urol 32, 1485–1492.
35. Ebbing, J., Seibert, F.S., Pagonas, N., Bauer, F., Miller, K., Kempkensteffen, C., Günzel, K., Bachmann, A., Seifert, H.H., Rentsch, C.A., Ardelt, P., Wetterauer, C., Amico, P., Babel, N. & Westhoff, T.H. 2016. Dynamics of urinary calprotectin after renal ischaemia. PLoS One 11, e0146395.
36. Ehrchen, J.M., Sunderkötter, C., Foell, D., Vogl, T. & Roth, J. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86, 557–566.
37. Evdokimova, V., Tognon, C.E., Benatar, T., Yang, W., Krutikov, K., Pollak, M., Sorensen, P.H.B. & Seth, A. 2012. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors. Sci Signal 5, ra92.
38. Fantuzzi, G., Reed, D.A. & Dinarello, C.A. 1999. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest 104, 761–767.
39. Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J., Norton, R. & SAFE Study Investigators. 2004. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350, 2247–2256.
40. Flo, T.H., Smith, K.D., Sato, S., Rodriguez, D.J., Holmes, M.A., Strong, R.K., Akira, S. & Aderem, A. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921.
41. Foell, D., Wittkowski, H., Ren, Z., Turton, J., Pang, G., Daebritz, J., Ehrchen, J., Heidemann, J., Borody, T., Roth, J. & Clancy, R. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol 216, 183–192.
42. Fraker, P.J., King, L.E., Lill-Elghanian, D. & Telford, W.G. 1995. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol 46, 57–76.
43. Franke, E.I., Vanderbrink, B.A., Hile, K.L., Zhang, H., Cain, A., Matsui, F. & Meldrum, K.K. 2012. Renal IL-18 production is macrophage independent during obstructive injury. PLoS One 7, e47417.
44. Fuchs, T.C., Frick, K., Emde, B., Czasch, S., von Landenberg, F. & Hewitt, P. 2012. Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials. Toxicol Pathol 40, 1031–1048.
45. Fujiu, K., Manabe, I. & Nagai, R. 2011. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 121, 3425–3441.
46. Gauer, S., Sichler, O., Obermüller, N., Holzmann, Y., Kiss, E., Sobkowiak, E., Pfeilschifter, J., Geiger, H., Mühl, H. & Hauser, I.A. 2007. IL-18 is expressed in the intercalated cell of human kidney. Kidney Int 72, 1081–1087.
47. de Geus, H.R.H., Bakker, J., Lesaffre, E.M.E.H. & le Noble, J.L.M.L. 2011. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 183, 907–914.
48. Gocze, I., Koch, M., Renner, P., Zeman, F., Graf, B.M., Dahlke, M.H., Nerlich, M., Schlitt, H.J., Kellum, J.A. & Bein, T. 2015. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One 10, e0120863.
49. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N. & Strong, R.K. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10, 1033–1043.
50. Gonzalez, F. & Vincent, F. 2012. Biomarkers for acute kidney injury in critically ill patients. Minerva Anestesiol 78, 1394–1403.
51. Gunnerson, K.J., Shaw, A.D., Chawla, L.S., Bihorac, A., Al-Khafaji, A., Kashani, K., Lissauer, M., Shi, J., Walker, M.G., Kellum, J.A. & Sapphire Topaz Investigators. 2016. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg 80, 243–249.
52. Haase, M., Bellomo, R., Story, D., Davenport, P. & Haase-Fielitz, A. 2008. Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care 12, R96.
53. Hall, I.E., Coca, S.G., Perazella, M.A., Eko, U.U., Luciano, R.L., Peter, P.R., Han, W.K. & Parikh, C.R. 2011. Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis. Clin J Am Soc Nephrol 6, 2740–2749.
54. Hammer, H.B., Odegard, S., Fagerhol, M.K., Landewé, R., van der Heijde, D., Uhlig, T., Mowinckel, P. & Kvien, T.K. 2007. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 66, 1093–1097.
55. Han, W.K., Bailly, V., Abichandani, R., Thadhani, R. & Bonventre, J.V. 2002. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62, 237–244.
56. Heller, F., Frischmann, S., Grünbaum, M., Zidek, W. & Westhoff, T.H. 2011. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol 6, 2347–2355.
57. Ho, J., Tangri, N., Komenda, P., Kaushal, A., Sood, M., Brar, R., Gill, K., Walker, S., MacDonald, K., Hiebert, B.M., Arora, R.C. & Rigatto, C. 2015. Urinary, plasma, and serum biomarkers’ utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis. Am J Kidney Dis 66, 993–1005.
58. Homsi, E., Janino, P. & de Faria, J.B.L. 2006. Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 69, 1385–1392.
59. Hoste, E.A.J., Clermont, G., Kersten, A., Venkataraman, R., Angus, D.C., De Bacquer, D. & Kellum, J.A. 2006. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 10, R73.
60. Hoste, E.A.J., McCullough, P.A., Kashani, K., Chawla, L.S., Joannidis, M., Shaw, A.D., Feldkamp, T., Uettwiller-Geiger, D.L., McCarthy, P., Shi, J., Walker, M.G., Kellum, J.A. & Sapphire Investigators. 2014. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant 29, 2054–2061.
61. Humphreys, B.D., Xu, F., Sabbisetti, V., Grgic, I., Movahedi Naini, S., Wang, N., Chen, G., Xiao, S., Patel, D., Henderson, J.M. et al. 2013. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest 123, 4023–4035.
62. Hvidberg, V., Jacobsen, C., Strong, R.K., Cowland, J.B., Moestrup, S.K. & Borregaard, N. 2005. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579, 773–777.
63. Ichimura, T., Bonventre, J.V., Bailly, V., Wei, H., Hession, C.A., Cate, R.L. & Sanicola, M. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273, 4135–4142.
64. Ichimura, T., Hung, C.-C., Yang, S.A., Stevens, J.L. & Bonventre, J.V. 2004. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 286, F552–63.
65. Ichimura, T., Asseldonk, E.J.P.V., Humphreys, B.D., Gunaratnam, L., Duffield, J.S. & Bonventre, J.V. 2008. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118, 1657–1668.
66. Imai, N., Yasuda, T., Kamijo-Ikemori, A., Shibagaki, Y. & Kimura, K. 2015. Distinct roles of urinary liver-type fatty acid-binding protein in non-diabetic patients with anemia. PLoS One 10, e0126990.
67. Ismail, O., Zhang, X., Bonventre, J.V. & Gunaratnam, L. 2015a. G protein, 12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis. Am J Physiol Renal Physiol ajprenal.00169.2015.
68. Ismail, O.Z., Zhang, X., Wei, J., Haig, A., Denker, B.M., Suri, R.S., Sener, A. & Gunaratnam, L. 2015b. Kidney injury molecule-1 protects against Gα12 activation and tissue damage in renal ischemia-reperfusion injury. Am J Pathol 185, 1207–1215.
69. Jo, S.K., Rosner, M.H. & Okusa, M.D. 2007. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2, 356–365.
70. Kamijo-Ikemori, A., Sugaya, T., Matsui, K., Yokoyama, T. & Kimura, K. 2011. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice. Nephrology 16, 539–544.
71. Kashani, K., Al-Khafaji, A., Ardiles, T., Artigas, A., Bagshaw, S.M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C.M., Chawla, L.S. et al. 2013. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17, R25.
72. Kellum, J.A., Bellomo, R. & Ronco, C. 2012. Kidney attack. JAMA 307, 2265–2266.
73. Khwaja, A. 2012. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120, c179–c184.
74. Koyner, J.L., Vaidya, V.S., Bennett, M.R., Ma, Q., Worcester, E., Akhter, S.A., Raman, J., Jeevanandam, V., O'Connor, M.F., Devarajan, P., Bonventre, J.V. & Murray, P.T. 2010. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5, 2154–2165.
75. Koyner, J.L., Garg, A.X., Coca, S.G., Sint, K., Thiessen-Philbrook, H., Patel, U.D., Shlipak, M.G. & Parikh, C.R. & TRIBE-AKI Consortium. 2012. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 23, 905–914.
76. Koyner, J.L., Davison, D.L., Brasha-Mitchell, E., Chalikonda, D.M., Arthur, J.M., Shaw, A.D., Tumlin, J.A., Trevino, S.A., Bennett, M.R., Kimmel, P.L., Seneff, M.G. & Chawla, L.S. 2015a. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 26, 2023–2031.
77. Koyner, J.L., Shaw, A.D., Chawla, L.S., Hoste, E.A.J., Bihorac, A., Kashani, K., Haase, M., Shi, J., Kellum, J.A. & Sapphire Investigators. 2015b. Tissue inhibitor metalloproteinase-2 (TIMP-2)·IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26, 1747–1754.
78. Krawczeski, C.D., Goldstein, S.L., Woo, J.G., Wang, Y., Piyaphanee, N., Ma, Q., Bennett, M. & Devarajan, P. 2011. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol 58, 2301–2309.
79. Landrier, J.-F., Thomas, C., Grober, J., Duez, H., Percevault, F., Souidi, M., Linard, C., Staels, B. & Besnard, P. 2004. Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent. J Biol Chem 279, 45512–45518.
80. Lin, X., Yuan, J., Zhao, Y. & Zha, Y. 2015. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. J Nephrol 28, 7–16.
81. Ma, Y., Lu, B., Ruan, W., Wang, H., Lin, J., Hu, H., Deng, H., Huang, Q. & Lai, M. 2008. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Exp Mol Pathol 85, 141–145.
82. Maatman, R.G., Van Kuppevelt, T.H. & Veerkamp, J.H. 1991. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J. 273, 759–766.
83. Medić, B., Rovčanin, B., Basta Jovanović, G., Radojević-Škodrić, S. & Prostran, M. 2015. Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice. Biomed Res Int 2015, 854070.
84. Meersch, M., Schmidt, C., Van Aken, H., Martens, S., Rossaint, J., Singbartl, K., Görlich, D., Kellum, J.A. & Zarbock, A. 2014. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One 9, e93460.
85. Megyesi, J., Safirstein, R.L. & Price, P.M. 1998. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101, 777–782.
86. Mehta, R.L., Pascual, M.T., Gruta, C.G., Zhuang, S. & Chertow, G.M. 2002. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 13, 1350–1357.
87. Melnikov, V.Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M.S., Dinarello, C.A., Schrier, R.W. & Edelstein, C.L. 2001. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107, 1145–1152.
88. Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J. & Devarajan, P. 2003. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14, 2534–2543.
89. Mishra, J., Mori, K., Ma, Q., Kelly, C., Barasch, J. & Devarajan, P. 2004. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24, 307–315.
90. Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M.M., Ma, Q., Kelly, C., Ruff, S.M., Zahedi, K., Shao, M., Bean, J., Mori, K., Barasch, J. & Devarajan, P. 2005. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365, 1231–1238.
91. Mori, K., Lee, H.T., Rapoport, D., Drexler, I.R., Foster, K., Yang, J., Schmidt-Ott, K.M., Chen, X., Li, J.Y., Weiss, S. et al. 2005. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115, 610–621.
92. Müller, H., Haug, U., Rothenbacher, D., Stegmaier, C. & Brenner, H. 2008. Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer. J Urol 180, 1309–1312; discussion 1312–1313.
93. Murugan, R., Karajala-Subramanyam, V., Lee, M., Yende, S., Kong, L., Carter, M., Angus, D.C., Kellum, J.A. & Genetic and Inflammatory Markers of Sepsis (GenIMS) Investigators. 2010. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77, 527–535.
94. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann, H.P., Wheeler, A.P., Bernard, G.R., Thompson, B.T., Hayden, D., deBoisblanc, B., Connors, A.F., Hite, R.D. & Harabin, A.L. 2006. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354, 2564–2575.
95. Negishi, K., Noiri, E., Sugaya, T., Li, S., Megyesi, J., Nagothu, K. & Portilla, D. 2007. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int 72, 348–358.
96. Negishi, K., Noiri, E., Maeda, R., Portilla, D., Sugaya, T. & Fujita, T. 2008. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 73, 1374–1384.
97. Nickolas, T.L., O'Rourke, M.J., Yang, J., Sise, M.E., Canetta, P.A., Barasch, N., Buchen, C., Khan, F., Mori, K., Giglio, J., Devarajan, P. & Barasch, J. 2008. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148, 810–819.
98. Nickolas, T.L., Schmidt-Ott, K.M., Canetta, P., Forster, C., Singer, E., Sise, M., Elger, A., Maarouf, O., Sola-Del Valle, D.A., O'Rourke, M. et al. 2012. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 59, 246–255.
99. Nisula, S., Yang, R., Poukkanen, M., Vaara, S.T., Kaukonen, K.M., Tallgren, M., Haapio, M., Tenhunen, J., Korhonen, A.M. & Pettilä, V. & FINNAKI Study Group. 2015. Predictive value of urine interleukin-18 in the evolution and outcome of acute kidney injury in critically ill adult patients. Br J Anaesth 114, 460–468.
100. Noiri, E., Doi, K., Negishi, K., Tanaka, T., Hamasaki, Y., Fujita, T., Portilla, D. & Sugaya, T. 2009. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 296, F669–79.
101. Novick, D., Kim, S.H., Fantuzzi, G., Reznikov, L.L., Dinarello, C.A. & Rubinstein, M. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10, 127–136.
102. Novick, D., Kim, S., Kaplanski, G. & Dinarello, C.A. 2013. Interleukin-18, more than a Th1 cytokine. Semin Immunol 25, 439–448.
103. Pajek, J., Škoberne, A., Šosterič, K., Adlešič, B., Leskošek, B., Bučar Pajek, M., Osredkar, J. & Lindič, J. 2014. Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function. BMC Nephrol 5, 50.
104. Paragas, N., Qiu, A., Zhang, Q., Samstein, B., Deng, S.-X., Schmidt-Ott, K.M., Viltard, M., Yu, W., Forster, C.S., Gong, G. et al. 2011. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17, 216–222.
105. Paragas, N., Kulkarni, R., Werth, M., Schmidt-Ott, K.M., Forster, C., Deng, R., Zhang, Q., Singer, E., Klose, A.D., Shen, T.H. et al. 2014. α-Intercalated cells defend the urinary system from bacterial infection. J Clin Invest 124, 2963–2976.
106. Parikh, C.R., Coca, S.G., Thiessen-Philbrook, H., Shlipak, M.G., Koyner, J.L., Wang, Z., Edelstein, C.L., Devarajan, P., Patel, U.D., Zappitelli, M., Krawczeski, C.D., Passik, C.S., Swaminathan, M. & Garg, A.X. & TRIBE-AKI Consortium. 2011. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22, 1748–1757.
107. Parikh, C.R., Thiessen-Philbrook, H., Garg, A.X., Kadiyala, D., Shlipak, M.G., Koyner, J.L., Edelstein, C.L., Devarajan, P., Patel, U.D., Zappitelli, M., Krawczeski, C.D., Passik, C.S. & Coca, S.G. 2013. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 8, 1079–1088.
108. Parravicini, E., Nemerofsky, S.L., Michelson, K.A., Huynh, T.K., Sise, M.E., Bateman, D.A., Lorenz, J.M. & Barasch, J.M. 2010. Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants. Pediatr Res 67, 636–640.
109. Payen, D., Lukaszewicz, A.-C., Belikova, I., Faivre, V., Gelin, C., Russwurm, S., Launay, J.-M. & Sevenet, N. 2008. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 34, 1371–1376.
110. Pennemans, V., Rigo, J.-M., Faes, C., Reynders, C., Penders, J. & Swennen, Q. 2013. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?. Clin Chem Lab Med 51, 1795–1802.
111. Pianta, T.J., Peake, P.W., Pickering, J.W., Kelleher, M., Buckley, N.A. & Endre, Z.H. 2015a. Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function. Transplantation 99, 171–179.
112. Pianta, T.J., Peake, P.W., Pickering, J.W., Kelleher, M., Buckley, N.A. & Endre, Z.H. 2015b. Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation. Transpl Int 28, 1392–1404.
113. Pilarczyk, K., Edayadiyil-Dudasova, M., Wendt, D., Demircioglu, E., Benedik, J., Dohle, D.S., Jakob, H. & Dusse, F. 2015. Urinary [TIMP-2]*[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care 99, 171–179.
114. Prowle, J.R., Calzavacca, P., Licari, E., Ligabo, E.V., Echeverri, J.E., Bagshaw, S.M., Haase-Fielitz, A., Haase, M., Ostland, V., Noiri, E., Westerman, M., Devarajan, P. & Bellomo, R. 2015. Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass. Ren Fail 37, 408–416.
115. Prozialeck, W.C., Vaidya, V.S., Liu, J., Waalkes, M.P., Edwards, J.R., Lamar, P.C., Bernard, A.M., Dumont, X. & Bonventre, J.V. 2007. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 72, 985–993.
116. Ralib, A.M., Pickering, J.W., Shaw, G.M., Devarajan, P., Edelstein, C.L., Bonventre, J.V. & Endre, Z.H. 2012. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. J Am Soc Nephrol 23, 322–333.
117. Ramirez-Sandoval, J.C., Herrington, W. & Morales-Buenrostro, L.E. 2015. Neutrophil gelatinase-associated lipocalin in kidney transplantation: a review. Transplant Rev (Orlando) 29, 139–144.
118. Rodier, F., Campisi, J. & Bhaumik, D. 2007. Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35, 7475–7484.
119. Ronco, C., Kellum, J.A. & Haase, M. 2012. Subclinical AKI is still AKI. Crit Care 16, 313.
120. Schmidt-Ott, K.M. 2011. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury–where do we stand today?. Nephrol Dial Transplant 26, 762–764.
121. Schmidt-Ott, K.M., Mori, K., Li, J.Y., Kalandadze, A., Cohen, D.J., Devarajan, P. & Barasch, J. 2007. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18, 407–413.
122. Schröppel, B., Krüger, B., Walsh, L., Yeung, M., Harris, S., Garrison, K., Himmelfarb, J., Lerner, S.M., Bromberg, J.S., Zhang, P.L. et al. 2010. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 21, 536–542.
123. Seeliger, S., Vogl, T., Engels, I.H., Schröder, J.M., Sorg, C., Sunderkötter, C. & Roth, J. 2003. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol 163, 947–956.
124. Seibert, F.S., Pagonas, N., Arndt, R., Heller, F., Dragun, D., Persson, P., Schmidt-Ott, K., Zidek, W. & Westhoff, T.H. 2013. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Acta Physiol (Oxf) 207, 700–708.
125. Seibert, F.S., Rosenberger, C., Mathia, S., Arndt, R., Arns, W., Andrea, H., Pagonas, N., Bauer, F., Zidek, W. & Westhoff, T.H. 2016. Urinary calprotectin differentiates between prerenal and intrinsic acute renal allograft failure. Transplantation [Epub ahead of print].
126. Seo, D.-W., Li, H., Qu, C.-K., Oh, J., Kim, Y.-S., Diaz, T., Wei, B., Han, J.-W. & Stetler-Stevenson, W.G. 2006. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem 281, 3711–3721.
127. Shao, X., Tian, L., Xu, W., Zhang, Z., Wang, C., Qi, C., Ni, Z. & Mou, S. 2014. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS One 9, e84131.
128. Singer, E., Elger, A., Elitok, S., Kettritz, R., Nickolas, T.L., Barasch, J., Luft, F.C. & Schmidt-Ott, K.M. 2011. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes. Kidney Int 80, 405–414.
129. Singer, E., Markó, L., Paragas, N., Barasch, J., Dragun, D., Müller, D.N., Budde, K. & Schmidt-Ott, K.M. 2013. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) 207, 663–672.
130. Smathers, R.L. & Petersen, D.R. 2011. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics 5, 170–191.
131. Smith, G.L., Lichtman, J.H., Bracken, M.B., Shlipak, M.G., Phillips, C.O., DiCapua, P. & Krumholz, H.M. 2006. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47, 1987–1996.
132. Stríz, I. & Trebichavský, I. 2004. Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53, 245–253.
133. Supavekin, S., Zhang, W., Kucherlapati, R., Kaskel, F.J., Moore, L.C. & Devarajan, P. 2003. Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63, 1714–1724.
134. Sweetser, D.A., Heuckeroth, R.O. & Gordon, J.I. 1987. The metabolic significance of mammalian fatty-acid-binding proteins: abundant proteins in search of a function. Annu Rev Nutr 7, 337–359.
135. Tan, N.-S., Shaw, N.S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W. & Noy, N. 2002. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 22, 5114–5127.
136. Taulan, M., Paquet, F., Argiles, A., Demaille, J. & Romey, M.-C. 2006. Comprehensive analysis of the renal transcriptional response to acute uranyl nitrate exposure. BMC Genom 7, 2.
137. Tepel, M., Borst, C., Bistrup, C., Marcussen, N., Pagonas, N., Seibert, F.S., Arndt, R., Zidek, W. & Westhoff, T.H. 2014. Urinary calprotectin and posttransplant renal allograft injury. PLoS One 9, e113006.
138. van Timmeren, M.M., van den Heuvel, M.C., Bailly, V., Bakker, S.J.L., van Goor, H. & Stegeman, C.A. 2007. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212, 209–217.
139. Vaidya, V.S., Ozer, J.S., Dieterle, F., Collings, F.B., Ramirez, V., Troth, S., Muniappa, N., Thudium, D., Gerhold, D., Holder, D.J. et al. 2010. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28, 478–485.
140. Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M.A.D., Nacken, W., Foell, D., van der Poll, T., Sorg, C. & Roth, J. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13, 1042–1049.
141. Waikar, S.S., Betensky, R.A. & Bonventre, J.V. 2009. Creatinine as the gold standard for kidney injury biomarker studies?. Nephrol Dial Transplant 24, 3263–3265.
142. Wang, G., Gong, Y., Anderson, J., Sun, D., Minuk, G., Roberts, M.S. & Burczynski, F.J. 2005. Antioxidative function of L-FABP in L-FABP stably transfected chang liver cells. Hepatology 42, 871–879.
143. Wang, J., Long, Q., Zhang, W. & Chen, N. 2012. Protective effects of exogenous interleukin 18-binding protein in a rat model of acute renal ischemia-reperfusion injury. Shock 37, 333–340.
144. Wetz, A.J., Richardt, E.M., Wand, S., Kunze, N., Schotola, H., Quintel, M., Bräuer, A. & Moerer, O. 2015. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?. Crit Care 19, 3.
145. Witzgall, R., Brown, D., Schwarz, C. & Bonventre, J.V. 1994. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93, 2175–2188.
146. Wu, H., Craft, M.L., Wang, P., Wyburn, K.R., Chen, G., Ma, J., Hambly, B. & Chadban, S.J. 2008. IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol 19, 2331–2341.
147. Wu, V.-C., Wu, C.-H., Huang, T.-M., Wang, C.-Y., Lai, C.-F., Shiao, C.-C., Chang, C.-H., Lin, S.-L., Chen, Y.-Y., Chen, Y.-M. et al. 2014. Long-term risk of coronary events after AKI. J Am Soc Nephrol 25, 595–605.
148. Xu, Y., Xie, Y., Shao, X., Ni, Z. & Mou, S. 2015. L-FABP: a novel biomarker of kidney disease. Clin Chim Acta 445, 85–90.
149. Yamamoto, T., Noiri, E., Ono, Y., Doi, K., Negishi, K., Kamijo, A., Kimura, K., Fujita, T., Kinukawa, T., Taniguchi, H., Nakamura, K., Goto, M., Shinozaki, N., Ohshima, S. & Sugaya, T. 2007. Renal L-type fatty acid–binding protein in acute ischemic injury. J Am Soc Nephrol 18, 2894–2902.
150. Yang, J., Goetz, D., Li, J.Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R. & Barasch, J. 2002. An iron delivery pathway mediated by a lipocalin. Mol Cell 10, 1045–1056.
151. Yang, Q.-H., Liu, D.-W., Long, Y., Liu, H.-Z., Chai, W.-Z. & Wang, X.-T. 2009. Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 58, 459–464.
152. Zhao, Y.Y., Weir, M.A., Manno, M., Cordy, P., Gomes, T., Hackam, D.G., Juurlink, D.N., Mamdani, M., Moist, L., Parikh, C.R., Paterson, J.M., Wald, R., Yao, Z. & Garg, A.X. 2012. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med 156, 560–569.
153. Zheng, J., Xiao, Y., Yao, Y., Xu, G., Li, C., Zhang, Q., Li, H. & Han, L. 2013. Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children. Pediatr Cardiol 34, 880–886.
154. Zhou, F., Luo, Q., Wang, L. & Han, L. 2016. Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis. Eur J Cardiothorac Surg 49, 746–755.
155. Zuo, S., Liu, C., Wang, J., Wang, F., Xu, W., Cui, S., Yuan, L., Chen, X., Fan, W., Cui, M. & Song, G. 2012. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells. J Cancer Res Clin Oncol 138, 1045–1055.